Development Level

Tbio 61 | 11,445
Tchem 10 | 1,598
Tdark 6 | 6,588
Tclin 5 | 613

Collection

Ion Channel: IDG Consortium (T... 2 | 99
Kinase: IDG Consortium (Comple... 2 | 37
GPCR: IDG Consortium (Complete... 1 | 25
Kinase: IDG Consortium (Target... 1 | 125

IMPC Phenotype

preweaning lethality, complete... 3 | 979
preweaning lethality, incomple... 3 | 499
abnormal behavior 2 | 298
abnormal testis morphology 2 | 43
decreased leukocyte cell numbe... 2 | 73
decreased mean corpuscular vol... 2 | 79
decreased vertical activity 2 | 208
hyperactivity 2 | 148
improved glucose tolerance 2 | 79
small testis 2 | 58
abnormal epididymis morphology 1 | 42
abnormal kidney morphology 1 | 65
abnormal optic disc morphology 1 | 10
abnormal retina morphology 1 | 71
abnormal seminal vesicle morph... 1 | 114
abnormal vertebrae morphology 1 | 18
decreased circulating alanine ... 1 | 47
decreased circulating bilirubi... 1 | 19
decreased circulating choleste... 1 | 93
decreased circulating phosphat... 1 | 27
decreased lean body mass 1 | 135
decreased red blood cell distr... 1 | 41
decreased startle reflex 1 | 75
decreased total body fat amoun... 1 | 207
edema 1 | 59
embryonic lethality prior to o... 1 | 239
embryonic lethality prior to t... 1 | 278
enlarged epididymis 1 | 31
enlarged seminal vesicle 1 | 10
increased blood urea nitrogen ... 1 | 48
increased circulating alkaline... 1 | 122
increased circulating calcium ... 1 | 34
increased circulating chloride... 1 | 41
increased circulating magnesiu... 1 | 10
increased fasted circulating g... 1 | 76
increased or absent threshold ... 1 | 101
increased vertical activity 1 | 24
limb grasping 1 | 41
premature death 1 | 5
prenatal lethality prior to he... 1 | 87
prolonged QT interval 1 | 38
prolonged ST segment 1 | 36
thrombocytopenia 1 | 56

Disease

Carcinoma 61 | 11,493
glioblastoma 45 | 5,792
medulloblastoma, large-cell 44 | 6,241
ependymoma 42 | 4,679
ovarian cancer 41 | 8,520
atypical teratoid / rhabdoid tumor 40 | 5,112
psoriasis 37 | 6,694
adult high grade glioma 34 | 3,801
osteosarcoma 32 | 7,950
oligodendroglioma 30 | 2,850
Kidney cancer 28 | 2,613
astrocytic glioma 27 | 2,597
group 3 medulloblastoma 27 | 4,104
Astrocytoma, Pilocytic 24 | 3,081
lung cancer 22 | 4,740
primitive neuroectodermal tumor 22 | 3,035
Breast cancer 20 | 3,578
lung carcinoma 19 | 2,843
Cancer 18 | 2,499
Schizophrenia 17 | 1,160
intraductal papillary-mucinous neoplasm (IPMN) 16 | 3,291
pituitary cancer 16 | 1,972
intraductal papillary-mucinous carcinoma (IPMC) 15 | 2,989
subependymal giant cell astrocytoma 15 | 2,287
Bipolar Disorder 14 | 666
intraductal papillary-mucinous adenoma (IPMA) 14 | 2,955
Alzheimer's disease 13 | 658
group 4 medulloblastoma 13 | 1,855
non-small cell lung cancer 13 | 2,890
invasive ductal carcinoma 12 | 2,951
pancreatic cancer 12 | 2,398
Liver cancer 11 | 604
Pick disease 11 | 1,894
Intellectual disability 10 | 1,016
lung adenocarcinoma 10 | 2,716
malignant mesothelioma 10 | 3,232
astrocytoma 9 | 1,146
breast carcinoma 9 | 1,638
interstitial cystitis 9 | 2,312
Epilepsy 8 | 792
Parkinson's disease 8 | 392
Seizures 8 | 596
cystic fibrosis 8 | 1,696
ductal carcinoma in situ 8 | 1,745
pediatric high grade glioma 8 | 1,064
Autosomal recessive predisposition 7 | 1,442
Depressive disorder 7 | 409
Dull intelligence 7 | 645
Low intelligence 7 | 645
Mental Retardation 7 | 645
Mental deficiency 7 | 645
Multiple Sclerosis 7 | 540
Poor school performance 7 | 645
Alcoholic Intoxication, Chronic 6 | 289
Breast Neoplasms 6 | 445
Down syndrome 6 | 499
Major Depressive Disorder 6 | 301
Mammary Neoplasms 6 | 425
Mental Depression 6 | 333
Psychotic Disorders 6 | 151
adrenocortical carcinoma 6 | 1,428
colon cancer 6 | 1,478
tuberculosis 6 | 2,010
Atopic dermatitis 5 | 952
Autistic Disorder 5 | 364
Brain disease 5 | 96
Cerebrovascular disease 5 | 238
Highly variable severity 5 | 157
Hyperactive behavior 5 | 91
Hypertensive disease 5 | 292
Melanoma 5 | 711
Neurodegenerative disease 5 | 414
Neuropathy 5 | 261
Obesity 5 | 678
Skin cancer 5 | 469
Supratentorial primitive neuroectodermal tumor 5 | 6
Unipolar Depression 5 | 250
Variable expressivity 5 | 157
medulloblastoma 5 | 720
primary pancreatic ductal adenocarcinoma 5 | 1,109
spina bifida 5 | 1,074
Amyotrophic lateral sclerosis 4 | 451
Cardiovascular system disease 4 | 246
Colorectal Neoplasms 4 | 243
Craniofacial Abnormalities 4 | 151
Dementia 4 | 175
Endometrial cancer 4 | 311
Hypertension 4 | 396
Liver Cirrhosis, Experimental 4 | 769
Mood Disorders 4 | 184
Muscle Spasticity 4 | 195
Paraplegia 4 | 74
Rheumatoid arthritis 4 | 1,191
Toxic encephalopathy 4 | 141
dermatomyositis 4 | 966
diabetes mellitus 4 | 1,728
fibroadenoma 4 | 559
juvenile dermatomyositis 4 | 1,187
nasopharyngeal carcinoma 4 | 1,058
posterior fossa group A ependymoma 4 | 468

Tissue

Endocrine System 82 | 18,159
Nervous System 80 | 16,725
Digestive Tract 78 | 17,369
Female tissues 78 | 17,400
Skin and soft tissues 78 | 17,230
Male tissues 77 | 17,142
Urinary Tract 76 | 16,678
Blood and immune system 75 | 16,909
Liver and Pancreas 75 | 16,750
Respiratory system 74 | 16,393
Cardiovascular System 63 | 15,192

Target Family

Non-IDG 57 | 12,091
Enzyme 9 | 4,145
Kinase 6 | 634
Transcription Factor 4 | 1,400
GPCR 3 | 408
Ion Channel 2 | 344
Transporter 1 | 473

GO Process

axonogenesis 82 | 82
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Atlastin-1 ATL1 Tbio Non-IDG -2.07795 119.7 164
Numb-like protein NUMBL Tbio Non-IDG -2.50313 317.9 171
SLIT and NTRK-like protein 1 SLITRK1 Tbio Non-IDG -2.74906 555.5 206
Epiphycan EPYC Tbio Non-IDG -1.62043 40.7 82
Serine/threonine-protein kinase BRSK2 BRSK2 Tchem Kinase -1.92813 85.3 187
Contactin-4 CNTN4 Tbio Non-IDG -1.54832 35.6 117
Phosphatidylinositol transfer protein alpha isoform PITPNA Tbio Non-IDG -1.53999 36.3 126
SLIT and NTRK-like protein 3 SLITRK3 Tbio Non-IDG -0.57320 3.62 79
SLIT and NTRK-like protein 5 SLITRK5 Tbio Non-IDG -0.83589 7.00 95
POU domain, class 4, transcription factor 1 POU4F1 Tbio Transcription Factor -2.19846 154.8 107